{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T17:19:52Z","timestamp":1789924792702,"version":"4.0.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,11]],"date-time":"2015-06-11T00:00:00Z","timestamp":1433980800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004963","name":"FP7","doi-asserted-by":"publisher","award":["242210"],"award-info":[{"award-number":["242210"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007687","name":"Swedish Society of Medicine","doi-asserted-by":"crossref","award":["SLS-330141"],"award-info":[{"award-number":["SLS-330141"]}],"id":[{"id":"10.13039\/501100007687","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Uppsala L\u00e4ns Landsting","award":["LUL-350891"],"award-info":[{"award-number":["LUL-350891"]}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["VR-523-2014-2048"],"award-info":[{"award-number":["VR-523-2014-2048"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Swedish Cancer Society","doi-asserted-by":"publisher","award":["12 0504"],"award-info":[{"award-number":["12 0504"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Swedish Cancer Society","doi-asserted-by":"publisher","award":["13 0410"],"award-info":[{"award-number":["13 0410"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["K2012-99X-21959-01-3"],"award-info":[{"award-number":["K2012-99X-21959-01-3"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2006-5038-36531-16"],"award-info":[{"award-number":["2006-5038-36531-16"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jns-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.jns.2015.06.019","type":"journal-article","created":{"date-parts":[[2015,6,14]],"date-time":"2015-06-14T12:54:06Z","timestamp":1434286446000},"page":"90-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Disease specific signature of circulating miR-150-5p and miR-21-5p in myasthenia gravis patients"],"prefix":"10.1016","volume":"356","author":[{"given":"Anna Rostedt","family":"Punga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Alimohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanel","family":"Punga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2015.06.019_bb0005","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1586\/eci.12.34","article-title":"Muscle autoantibodies in myasthenia gravis: beyond diagnosis?","volume":"8","author":"Meriggioli","year":"2012","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"10.1016\/j.jns.2015.06.019_bb0010","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/mus.23330","article-title":"Recommendations for myasthenia gravis clinical trials","volume":"45","author":"Benatar","year":"2012","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2015.06.019_bb0015","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1749-6632.2012.06787.x","article-title":"Biomarker development for myasthenia gravis","volume":"1275","author":"Kaminski","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jns.2015.06.019_bb0020","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrg2843","article-title":"The widespread regulation of microRNA biogenesis, function and decay","volume":"11","author":"Krol","year":"2010","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jns.2015.06.019_bb0025","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/sj.bjc.6603023","article-title":"MicroRNAs in cell proliferation, cell death, and tumorigenesis","volume":"94","author":"Hwang","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jns.2015.06.019_bb0030","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.clim.2012.04.005","article-title":"miRNA in systemic lupus erythematosus","volume":"144","author":"Amarilyo","year":"2012","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jns.2015.06.019_bb0035","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2165\/11631480-000000000-00000","article-title":"MicroRNAs in rheumatoid arthritis: potential role in diagnosis and therapy","volume":"26","author":"Filkova","year":"2012","journal-title":"BioDrugs"},{"key":"10.1016\/j.jns.2015.06.019_bb0040","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/ana.23880","article-title":"Circulating microRNAs as biomarkers for disease staging in multiple sclerosis","volume":"73","author":"Gandhi","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2015.06.019_bb0045","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nrclinonc.2014.5","article-title":"Clinical relevance of circulating cell-free microRNAs in cancer","volume":"11","author":"Schwarzenbach","year":"2014","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jns.2015.06.019_bb0050","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/acn3.24","article-title":"Circulating miRNAs in myasthenia gravis: miR-150-5p as a new potential biomarker","volume":"1","author":"Punga","year":"2014","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.jns.2015.06.019_bb0055","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2003-11-3900","article-title":"Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis","volume":"105","author":"Balandina","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jns.2015.06.019_bb0060","doi-asserted-by":"crossref","first-page":"7053","DOI":"10.1182\/blood-2010-12-326629","article-title":"Modulation of microRNA expression in human T-cell development: targeting of NOTCH3 by miR-150","volume":"117","author":"Ghisi","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jns.2015.06.019_bb0065","doi-asserted-by":"crossref","first-page":"R71","DOI":"10.1186\/gb-2005-6-8-r71","article-title":"MicroRNA profiling of the murine hematopoietic system","volume":"6","author":"Monticelli","year":"2005","journal-title":"Genome Biol."},{"key":"10.1016\/j.jns.2015.06.019_bb0070","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1212\/WNL.0b013e3181dc1b1e","article-title":"The MG composite: a valid and reliable outcome measure for myasthenia gravis","volume":"74","author":"Burns","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2015.06.019_bb0075","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1002\/mus.21185","article-title":"Construction of an efficient evaluative instrument for myasthenia gravis: the MG composite","volume":"38","author":"Burns","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2015.06.019_bb0080","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0003-4975(00)01595-2","article-title":"Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America","volume":"70","author":"Jaretzki","year":"2000","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.jns.2015.06.019_bb0085","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10072-006-0606-y","article-title":"Validation of the Swedish version of the disease-specific Myasthenia Gravis Questionnaire","volume":"27","author":"Rostedt","year":"2006","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jns.2015.06.019_bb0090","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3892\/mmr.2015.3428","article-title":"Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription quantitative polymerase chain reaction in patients with bladder cancer","volume":"12","author":"Wang","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jns.2015.06.019_bb0095","doi-asserted-by":"crossref","first-page":"e83025","DOI":"10.1371\/journal.pone.0083025","article-title":"Identification and validation of reference genes for qPCR detection of serum microRNAs in colorectal adenocarcinoma patients","volume":"8","author":"Zheng","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2015.06.019_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/imm.12367","article-title":"Immuno-miRs: critical regulators of T-cell development, function and ageing","volume":"144","author":"Kroesen","year":"2015","journal-title":"Immunology"},{"key":"10.1016\/j.jns.2015.06.019_bb0105","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of psoriasis","volume":"32","author":"Lowes","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jns.2015.06.019_bb0110","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jaut.2013.12.015","article-title":"Both Treg cells and Tconv cells are defective in the myasthenia gravis thymus: roles of IL-17 and TNF-alpha","volume":"52","author":"Gradolatto","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jns.2015.06.019_bb0115","first-page":"382","article-title":"Increased apoptosis of regulatory T cells in Crohn's disease","volume":"61","author":"Poniedzialek","year":"2014","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.jns.2015.06.019_bb0120","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.neulet.2011.08.021","article-title":"Expression and genetic analysis of miRNAs involved in CD4+ cell activation in patients with multiple sclerosis","volume":"504","author":"Fenoglio","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jns.2015.06.019_bb0125","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/emmm.201100171","article-title":"Silencing of microRNA-21 in vivo ameliorates autoimmune splenomegaly in lupus mice","volume":"3","author":"Garchow","year":"2011","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.jns.2015.06.019_bb0130","doi-asserted-by":"crossref","first-page":"12030","DOI":"10.1073\/pnas.1101450108","article-title":"The microRNA-21-PDCD4 axis prevents type 1 diabetes by blocking pancreatic beta cell death","volume":"108","author":"Ruan","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jns.2015.06.019_bb0135","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1136\/ard.2010.139857","article-title":"Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression","volume":"70","author":"Stagakis","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jns.2015.06.019_bb0140","doi-asserted-by":"crossref","first-page":"e76217","DOI":"10.1371\/journal.pone.0076217","article-title":"Dual role of miR-21 in CD4+ T-cells: activation-induced miR-21 supports survival of memory T-cells and regulates CCR7 expression in naive T-cells","volume":"8","author":"Smigielska-Czepiel","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2015.06.019_bb0145","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/gene.2013.69","article-title":"Comprehensive analysis of miRNA expression in T-cell subsets of rheumatoid arthritis patients reveals defined signatures of naive and memory Tregs","volume":"15","author":"Smigielska-Czepiel","year":"2014","journal-title":"Genes Immun."},{"key":"10.1016\/j.jns.2015.06.019_bb0150","doi-asserted-by":"crossref","first-page":"5476","DOI":"10.1182\/blood-2011-04-347526","article-title":"Human microRNA-27a* targets Prf1 and GzmB expression to regulate NK-cell cytotoxicity","volume":"118","author":"Kim","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jns.2015.06.019_bb0155","doi-asserted-by":"crossref","first-page":"e91927","DOI":"10.1371\/journal.pone.0091927","article-title":"Analysis of serum miRNA profiles of myasthenia gravis patients","volume":"9","author":"Nogales-Gadea","year":"2014","journal-title":"PLoS One"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X15003603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X15003603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T19:07:30Z","timestamp":1566846450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X15003603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":31,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0022510X15003603"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2015.06.019","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disease specific signature of circulating miR-150-5p and miR-21-5p in myasthenia gravis patients","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2015.06.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}